Safety, Immunogenicity, and Protective Efficacy of the Whole-Cell/Recombinant B Subunit (WC/rBS) Oral Cholera Vaccine Against Travelers' Diarrhea-Reference-Cited by-同舟云学术

Safety, Immunogenicity, and Protective Efficacy of the Whole-Cell/Recombinant B Subunit (WC/rBS) Oral Cholera Vaccine Against Travelers' Diarrhea

Published:1995-03-01 Issue:1 Volume:2 Page:22-27
ISSN:1195-1982
Container-title:Journal of Travel Medicine
language:en
Short-container-title:J Travel Med

Author:

Scerpella Ernesto G.,Sanchez Jose L.,Mathewson John J.,Torres-Cordero Juan V.,Sadoff Jerald C.,Svennerholm Ann-Mari,DuPont Herbert L.,Taylor David N.,Ericsson Charles D.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/jtm/article-pdf/2/1/22/5188680/jtm2-0022.pdf

Reference13 articles.

1. Okhuysen PC Ericsson CD. Travelers' diarrhea: prevention and treatment. Med Clin North Am 1992; 76:1357–1373.

2. Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea

3. Levine MM Kaper JB Black RE Clements ML. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev 1983; 47:510–550.

4. Mucosal Antitoxic and Antibacterial Immunity after Cholera Disease and after Immunization with a Combined B Subunit-Whole Cell Vaccine

5. Cross-Protection by B Subunit-Whole Cell Cholera Vaccine Against Diarrhea Associated with Heat-Labile Toxin-Producing Enterotoxigenic Escherichia coli: Results of a Large-Scale Field Trial

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bismuth subsalicylate, probiotics, rifaximin and vaccines for the prevention of travelers’ diarrhea: a systematic review and network meta-analysis;Frontiers in Pharmacology;2024-04-18

2. Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic E. coli Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701);Microorganisms;2024-04-03

3. Vaccine Strategies to Elicit Mucosal Immunity;Vaccines;2024-02-13

4. Efficacy of an Enterotoxigenic Escherichia coli (ETEC) Vaccine on the Incidence and Severity of Traveler’s Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score;Microorganisms;2023-09-27

5. Vaccines Against Diarrhea Caused by Noncholera Bacteria;Plotkin's Vaccines;2023